Core Viewpoint - The stock of Yimai Sunshine (02522) rose over 6% in early trading, reflecting positive market sentiment following the completion of its first data transaction by its subsidiary, Beijing Yimai Information [1] Group 1: Company Developments - Yimai Sunshine completed its first data transaction on September 1, with its CT chest lesion annotation data listed on the Shanghai Data Exchange on August 25 and passing compliance review by the Beijing International Big Data Exchange [1] - The company signed a tripartite cooperation contract with a data technology company and the Beijing International Big Data Exchange, successfully completing the transaction [1] - This collaboration provides a new model for monetizing the company's core data assets and highlights its professional capabilities and market value in the medical imaging data sector [1] Group 2: Financial Activities - The company announced a plan to place 35 million shares, aiming to raise approximately HKD 562 million [1] - About 40% of the raised funds will be allocated to the development of data and artificial intelligence, focusing on enhancing capabilities in medical imaging data mining, annotation, and cleaning, as well as developing an AI application platform [1] - 30% of the funds will be used for continuous expansion of the company's medical imaging center business and enabling solution business through self-investment or acquisitions, targeting both domestic and overseas markets, including Hong Kong and Singapore [1]